2015 patent expiries valued at $170 bn.....""the patent expiry drugs are a massive opportunity for Indian pharma. All big players in the country have been extremely proactive and well prepared by lining up their pipeline to propel growth.""......I have no doubt Arun and his Indian connections are well prepared for this event and have lined NPH up to take full advantage of these new generics.......... https://www.pharmabiz.com/NewsDetails.aspx?aid=85348&sid=1